BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
12 Years to 45 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Qualifying Investigator's Global Assessment severity score
Qualifying number of non-inflammatory lesions
Qualifying number of inflammatory lesions
Facial hair (beard), excessive scarring, sunburn or other disfigurement that may obscure the accurate assessment of acne grade
Using medications that are reported to exacerbate acne
Any clinically relevant finding at their baseline physical examination or dermatological medical history such as severe systemic diseases or diseases of the facial skin
Have a known hypersensitivity or previous allergic reaction to any of the components
Patients who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days
Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures